-The Hindu The Supreme Court has denied Novartis a patent for its anti-cancer drug Gleevec. This leaves the door open for Indian pharmaceutical companies to produce their own versions of the drug. Since these are sold at roughly one tenth of the patented brand price, for thousands of cancer patients it means the difference between medicine and no medicine at all. It is not just cancer patients that will benefit, but...

-The Financial Express A patent law that is transparent, based on principles of good science & encourages innovation is in India's interest In 500 BC, in the Greek city of Sybaris, it was proclaimed that "encouragement was held out to all who should discover any new refinement in luxury, the profits arising from which were secured to the inventor by patent for the space of a year." England followed with the Statute...

-The Economic Times Should drug companies make clinical trials data public? All over the world, drug regulators are increasingly in favour of doing so, much to the discomfort of pharmaceutical companies, and the London-based European Medicines Agency (EMA) is the first mover in this regard. As the journal Nature reports, EMA is likely to do so by next year, at least for some clinical trials data. On April 19, all the...

-The Hindu The Justice Verma Committee report acts as a blueprint for the radical transformation of gender relations within the framework of constitutional guarantees and gender equality. However, the adoption of the Criminal Law Amendment Act 2013 by Parliament on March 19, 2013, does not go beyond legal change. Prof. Hasan argues that if political parties are serious about the rights of women, the Women's Representation Bill must be passed...

-The Indian Express No country has ever achieved prosperity without engaging with science and technology (S&T). The ascent of the West and its global domination owes much to its prowess in S&T. In Asia, Japan and South Korea and more recently China have taken the highway to prosperity by mastering technology and effectively dealing with complexity. Chinese economist Justin Yufi Lin in his book The Quest for Prosperity has argued that...